abstract |
The present invention relates to crystalline forms of 3-substituted 1,2,4-oxadiazole compounds, including anhydrous crystalline forms, methods for their preparation, and related pharmaceutical preparations thereof. The present invention also relates to formulations suitable for pharmaceutical, veterinary and agricultural-related applications. |